Search alternatives:
mean decrease » a decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
mean decrease » a decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
261
-
262
K-means++ clustering algorithm.
Published 2025“…Firstly, recursive feature elimination using cross validation (RFECV), maximum information coefficient (MIC), and mean decrease accuracy (MDA) methods were utilized to select population distribution feature factors. …”
-
263
-
264
-
265
Evaluation of a Dengue NS1 Antigen Detection Assay Sensitivity and Specificity for the Diagnosis of Acute Dengue Virus Infection
Published 2014“…We found significant variation in the sensitivity of the InBios NS1 ELISA kit depending on the serotype of the dengue virus and also found decreasing sensitivity the longer after the onset of illness, showing 100% sensitivity early during illness, but dropping below 50% by Day 7.…”
-
266
-
267
-
268
-
269
Pre-treatment with HMGB1 enhanced KA-induced up-regulation of P-gp in the epileptic brain.
Published 2015“…HMGB1 injection enhanced the over-expression of P-gp in the EP group mice while BoxA attenuated it. Scale bar: 50 μm. NS: normal saline control group; EP: KA-induced epileptic seizure group; EP+HMGB1: EP group pretreated with HMGB1; EP+BoxA: EP group pretreated with BoxA. …”
-
270
The effects of pretreatment with fingolimod-phosphate on BMECs in the presence of MS sera.
Published 2015“…Pretreatment with fingolimod-phosphate resulted in an increase in the claudin-5 protein levels (B) and TEER values (G) and a decrease in the VCAM-1 protein levels (F) in the BMECs, which were upregulated after exposure to the sera from all MS patients, including the RRMS-R, RRMS-S and SPMS patients, compared to that observed in the cells not pretreated with fingolimod-phosphate.…”
-
271
-
272
-
273
-
274
-
275
-
276
-
277
-
278
-
279
-
280